8.38
+0.36%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue, before interest expense
CN¥10.30bn
FY2016FY2025
Net income
CN¥1.96bn
FY2016FY2025
Total assets
CN¥203.31bn
FY2016FY2025
Shareholders' equity
CN¥52.51bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | CN¥10.30bn | CN¥3.86bn | CN¥3.42bn | CN¥3.42bn | CN¥3.28bn | CN¥1.79bn | CN¥1.45bn | CN¥1.32bn | CN¥1.33bn | CN¥1.78bn |
| Research and development | CN¥68.7m | CN¥26.9m | CN¥25.6m | CN¥20.0m | — | — | — | — | — | — |
| Operating income | CN¥3.70bn | CN¥1.45bn | CN¥1.78bn | CN¥1.76bn | CN¥2.02bn | CN¥1.18bn | CN¥588.4m | CN¥642.3m | CN¥451.9m | CN¥978.3m |
| Net income | CN¥1.96bn | CN¥340.1m | CN¥577.3m | CN¥656.7m | CN¥888.6m | CN¥503.1m | CN¥446.2m | CN¥43.3m | CN¥309.4m | CN¥522.1m |
| Diluted earnings per share | 0.34 | 0.12 | 0.20 | 0.23 | 0.31 | 0.21 | 0.23 | 0.02 | 0.16 | 0.27 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥203.31bn | CN¥97.21bn | CN¥87.13bn | CN¥74.38bn | CN¥65.94bn | CN¥39.56bn | CN¥24.32bn | CN¥18.22bn | CN¥20.60bn | CN¥20.53bn |
| Cash and short-term investments | CN¥84.72bn | CN¥59.34bn | CN¥49.67bn | CN¥40.22bn | CN¥34.95bn | CN¥20.55bn | CN¥11.88bn | CN¥10.99bn | CN¥10.67bn | CN¥9.63bn |
| Total liabilities | CN¥150.41bn | CN¥78.26bn | CN¥69.01bn | CN¥57.62bn | CN¥49.56bn | CN¥30.49bn | CN¥17.42bn | CN¥11.67bn | CN¥14.10bn | CN¥13.78bn |
| Debt | — | CN¥52.37bn | CN¥45.28bn | CN¥36.25bn | CN¥32.08bn | CN¥22.96bn | CN¥10.52bn | CN¥6.58bn | CN¥7.52bn | — |
| Shareholders' equity | CN¥52.51bn | CN¥18.58bn | CN¥17.77bn | CN¥16.76bn | CN¥16.38bn | CN¥9.07bn | CN¥6.90bn | CN¥6.55bn | CN¥6.50bn | CN¥6.48bn |
| Shares outstanding | 5,681m | 2,845m | 2,832m | 2,832m | 2,832m | 2,413m | 1,902m | 1,902m | 1,902m | 1,911m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | CN¥3.37bn | CN¥2.46bn | CN¥2.49bn | CN¥2.68bn | CN¥2.44bn | CN¥1.55bn | CN¥755.5m | CN¥839.4m |
| Operating income | CN¥1.04bn | CN¥604.7m | CN¥233.3m | CN¥778.7m | CN¥929.5m | CN¥496.7m | −CN¥383.4m | CN¥448.0m |
| Net income | CN¥914.8m | CN¥492.3m | CN¥242.5m | CN¥635.3m | CN¥751.1m | CN¥376.1m | CN¥1.3m | CN¥308.1m |
| Diluted earnings per share | 0.16 | 0.09 | 0.04 | 0.11 | 0.13 | 0.07 | 0.00 | 0.11 |
| Total assets | CN¥245.94bn | CN¥236.33bn | CN¥203.31bn | CN¥189.32bn | CN¥185.40bn | CN¥174.52bn | CN¥83.19bn | CN¥102.89bn |
| Cash and short-term investments | CN¥10.33bn | CN¥10.47bn | CN¥9.33bn | CN¥9.71bn | CN¥101.50bn | CN¥8.23bn | CN¥50.78bn | CN¥6.77bn |
| Debt | CN¥91.71bn | CN¥63.37bn | CN¥88.01bn | CN¥51.56bn | CN¥73.83bn | — | CN¥39.59bn | — |
| Shareholders' equity | CN¥52.47bn | CN¥53.31bn | CN¥52.51bn | CN¥52.02bn | CN¥51.09bn | CN¥50.49bn | CN¥15.90bn | CN¥18.36bn |
Financial ratios
Data as of 17 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | 36.0% | 58.8% | 66.2% | 88.8% | 61.7% | 94.3% |
| Net margin | 19.0% | 13.8% | 21.4% | 27.0% | 27.1% | 28.1% |
| Return on equity | 3.8% | 2.1% | 3.8% | 4.6% | 5.4% | 5.5% |
| Return on assets | 1.0% | 0.4% | 0.8% | 1.0% | 1.3% | 1.3% |
| Revenue growth | 266.9% | -8.0% | 10.5% | -13.5% | 56.9% | 19.1% |
| Earnings growth | 405.5% | -40.8% | -12.5% | -13.7% | 51.2% | 12.8% |
| Current ratio | 1.71x | 1.58x | 2.85x | 1.56x | 1.54x | 1.55x |
| Debt to equity | 1.66x | 1.34x | 3.35x | 2.15x | 1.12x | 1.31x |
| Equity ratio | 25.8% | 19.1% | 20.4% | 22.5% | 24.8% | 22.9% |
| Interest coverage | 2.74x | 1.28x | 1.66x | 2.32x | 2.15x | 3.37x |
| R&D as a share of sales | 0.7% | 1.1% | 1.0% | 0.8% | — | — |
| Buybacks as a share of market value | -99.7% | -0.5% | 0.0% | 0.0% | -17.3% | -26.9% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 44.4% | 41.9% | 12.5% |
| Operating income | 28.2% | 25.8% | 7.8% |
| Net income | 43.9% | 31.2% | 2.9% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 36.4% | 41.3% | 45.6% | 46.4% |
| Net margin | 16.2% | 16.8% | 18.9% | 22.0% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Price to earnings | 29.6 | 113.1 | 53.2 | 48.5 | 44.5 | 102.3 |
| Price to sales | 5.6 | 10.0 | 9.0 | 9.3 | 12.1 | 28.8 |
Dividends and splits
Per share, in the currency the company pays
Paid for 2 years. Last went ex-dividend on 5 Aug 2025.
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Paid in the year | 0.056 | 0.142 | 0.10 | 0.12 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.